LINDA SPADARO: Open Payments
NPI 1346957669 · BROOMALL, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$665 in 14 payments from 10 companies in 2025. Trend: 2023 $713 · 2024 $1,196 · 2025 $665
Food & beverage: $665
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $140 |
| Neuronetics, Inc. | 1 | $113 |
| Otsuka America Pharmaceutical, Inc. | 1 | $113 |
| Inspire Medical Systems, Inc. | 1 | $95 |
| Novo Nordisk Inc | 3 | $60 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $34 |
| Astellas Pharma US Inc | 1 | $25 |
| Lilly USA, LLC | 1 | $25 |
| Exact Sciences Corporation | 1 | $20 |
Products named: INGREZZA, NEUROSTAR TMS THERAPY SYSTEM, REXULTI, INSPIRE, AIRSUPRA, AUSTEDO XR, Wegovy, Veozah.
Industry payments across PA — which companies pay providers there.
